CS logo
small CS logo
Medipol University MF; Oncology Department

Istanbul, Turkey
University in Istanbul
Göztepe, Bodrum Kat, Anadolu Hisarı Mah. Kavacık Kavşağı No - 19 D2, D - Blok 1, 34810 Beykoz/İstanbul

About Medipol University MF; Oncology Department


Istanbul Medipol University is a private university in Istanbul, Turkey. It was founded by Turkey Education Health and Research Foundation in 2009. The founder of the foundation is Fahrettin Koca, who is the current Minister of Health of Turkey.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Medipol University MF; Oncology Department


During the past decade, Medipol University MF; Oncology Department conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Medipol University MF; Oncology Department


According to Clinical.Site data, the most researched conditions in "Medipol University MF; Oncology Department" are "Non-Small Cell Lung Cancer" (2 trials), "Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials), "Locally Advanced or Metastatic Breast Cancer" (1 trials) and "NSCLC" (1 trials). Many other conditions were trialed in "Medipol University MF; Oncology Department" in a lesser frequency.

Clinical Trials Intervention Types at Medipol University MF; Oncology Department


Most popular intervention types in "Medipol University MF; Oncology Department" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (4 trials), "Carboplatin" (3 trials), "Paclitaxel" (3 trials) and "Alectinib" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Medipol University MF; Oncology Department


The vast majority of trials in "Medipol University MF; Oncology Department" are 11 trials for "All" genders.

Clinical Trials Status at Medipol University MF; Oncology Department


Currently, there are NaN active trials in "Medipol University MF; Oncology Department". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Medipol University MF; Oncology Department, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medipol University MF; Oncology Department, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".